As the pharmaceutical industry’s expansion into emerging markets meets the desire of Asian governments to speed approval of innovative products, demand for clinical trials is soaring in the Asian region. By 2021, the global market for clinical trials is expected to reach... Read More
Introduction Despite its small population of 5.6 million, Singapore is a key drug market for Western pharmaceutical companies. Singapore’s pharmaceutical market is currently estimated to be about $820 million. It is expected to grow at a steady rate of 6% in 2017,... Read More
Thailand, with a population of 68 million, is Southeast Asia’s third most populous country after Indonesia (256 million) and the Philippines (104 million). As the country continues to undergo economic growth and demographic changes, Thailand’s pharmaceutical market presents numerous opportunities for foreign... Read More
In India, 90% of clinical trials over the past few years have ended abruptly primarily due to contract research organizations (CROs) and drug companies using Indian patients as “guinea pigs”. Despite this dramatic slowdown in clinical trials, the Indian government is taking... Read More
On August 24, 2016 the CFDA published a notice on clinical trial fraud. The eight clauses of the notice define clinical trial fraud, explain how responsibility is apportioned, give opportunities for offenders to withdraw fraudulent data, and lay out the consequences for... Read More
South Korea, a country in Northeast Asia with a population of 49 million, has become a global clinical trial hub over the past decade. The Korean government has offered a variety of incentives to support the countrys biotechnology and clinical trial industries.... Read More
Over the past 10 years, South Korea has become a hub for multinational clinical trials. The Korean government offers a variety of incentives to the clinical trial industry. The country also boasts a well-defined regulatory process and one of the fastest clinical... Read More
在过去的10年里，韩国已经成为跨国临床试验中心。韩国政府向临床试验产业提供了各种激励措施。韩国拥有一个透明的监管体系，更是在亚洲临床试验研究发展最快的的国家之一。许多主要的国际临床研究机构和制药公司都在韩国开展临床试验工作。 Read More
This report on Asian CROs provides a comprehensive list of contract research organizations in Asia. The countries covered include: Japan, Taiwan, Korea, Singapore, Hong Kong, India, China, Malaysia, Philippines, Indonesia, Thailand and Vietnam. Included for each CRO are contact information, description of... Read More
The medical device market in India grew to $3 billion by the end of 2011. According to a recent report, that figure should more than triple over the next ten years, to reach $10 billion by 2022. While India's market grows at... Read More